IDiyas

For the Inventor, By the Inventor

Kanagawa, Japan

Kohei Takeuchi

USPTO Granted Patents = 13 

 

Average Co-Inventor Count = 12.5

ph-index = 2

Forward Citations = 32(Granted Patents)


Company Filing History:

goldMedal13 out of 1,177 
 
Takeda Pharmaceutical Company Limited
 patents

Years Active: 2019-2025

Loading Chart...
Loading Chart...
13 patents (USPTO):
1. 12421188 - Heterocyclic compound and use thereof (2025-09-23),
2. 12415782 - Heterocyclic compound and use thereof (2025-09-16),
3. 12404237 - Method of treating excessive sleepiness and/or cataplexy using n-{2-(([1,1'-biphenyl]-3-yl)methyl)pyrrolidin-3-yl}sulfonamide derivatives (2025-09-02),
4. 12091410 - Heterocyclic compound (2024-09-17),
5. 12071434 - Heterocyclic compound (2024-08-27),
6. 11987586 - Pyrrolo[1,2-c]imidazole derivatives as orexin type 2 receptor agonists (2024-05-21),
7. 11655241 - Heterocyclic compound and use thereof (2023-05-23),
8. 11440883 - Heterocyclic compound and use thereof (2022-09-13),
9. 11319286 - Heterocyclic compound and application thereof (2022-05-03),
10. 11059780 - Substituted pyrrolidine compound and use thereof (2021-07-13),
11. 11034700 - Substituted pyrrolidine compound and use thereof (2021-06-15),
12. 10584097 - Heterocyclic compound and use thereof (2020-03-10),
13. 10428023 - Heterocyclic compound and use thereof (2019-10-01),

Title: Unveiling the Innovative Inventor: Kohei Takeuchi

Introduction:

In the realm of groundbreaking patents in the field of pharmaceuticals, Kohei Takeuchi stands out as a visionary inventor. Residing in Kanagawa, Japan, Takeuchi is renowned for his exceptional contributions to the domain of medicinal chemistry. With an impressive track record of 7 patents to his name, his inventive spirit knows no bounds.

Latest Patents:

Among his latest patents, Takeuchi has pioneered a remarkable heterocyclic compound and its applications. The patent focuses on a compound with orexin type 2 receptor agonist activity, offering promising implications for the prophylaxis and treatment of narcolepsy. This revolutionary discovery is encapsulated in a compound represented by the formula (I).

Career Highlights:

Takeuchi's professional journey is intricately linked with the reputable Takeda Pharmaceutical Company Limited. Within this esteemed organization, he has channelled his expertise to drive innovation and redefine the boundaries of pharmaceutical advancements. His relentless pursuit of excellence has positioned him as a trailblazer in the pharmaceutical industry.

Collaborations:

Collaboration plays a pivotal role in Takeuchi's innovative endeavors. His notable coworkers, Yuichi Kajita and Yuhei Miyanohana, have been instrumental in shaping his inventive pursuits. Through collaborative efforts and collective ingenuity, the team has harnessed synergies to unlock new frontiers in pharmaceutical research and development.

Conclusion:

In conclusion, Kohei Takeuchi emerges as a beacon of creativity and dedication in the realm of pharmaceutical inventions. His exceptional patents, coupled with his strategic collaborations and pivotal role at Takeda Pharmaceutical Company Limited, underscore his indelible impact on the landscape of medicinal chemistry. As a visionary inventor, Takeuchi continues to inspire and pave the way for transformative breakthroughs in the field.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…